Protective role of melatonin in neonatal diseases

Eloisa Gitto, Lucia Marseglia, Sara Manti, Gabriella D'Angelo, Ignazio Barberi, Carmelo Salpietro, Russel J Reiter

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Oxidative stress contributes to the severity of several newborn conditions to the extent that Saugstad coined the phrase "oxygen radical diseases of neonatology." In order to counteract free radicals damage many strategies to augment antioxidant status in ill-term and preterm infants have been proposed and several medications have been experimented with mixed results. Several studies have tested the efficacy of melatonin to counteract oxidative damage in diseases of newborns such as chronic lung disease, perinatal brain injury, necrotizing enterocolitis, and retinopathy of prematurity, giving promising results. The peculiar perinatal susceptibility to oxidative stress indicates that prophylactic use of antioxidants as melatonin could help to prevent or at least reduce oxidative stress related diseases in newborns. However, more studies are needed to confirm these beneficial effects.

Original languageEnglish (US)
Article number980374
JournalOxidative Medicine and Cellular Longevity
DOIs
StatePublished - 2013

Fingerprint

Infant, Newborn, Diseases
Oxidative stress
Melatonin
Oxidative Stress
Newborn Infant
Antioxidants
Neonatology
Pulmonary diseases
Retinopathy of Prematurity
Necrotizing Enterocolitis
Premature Infants
Brain Injuries
Lung Diseases
Free Radicals
Reactive Oxygen Species
Brain
Chronic Disease

ASJC Scopus subject areas

  • Cell Biology
  • Aging
  • Biochemistry

Cite this

Gitto, E., Marseglia, L., Manti, S., D'Angelo, G., Barberi, I., Salpietro, C., & Reiter, R. J. (2013). Protective role of melatonin in neonatal diseases. Oxidative Medicine and Cellular Longevity, [980374]. https://doi.org/10.1155/2013/980374

Protective role of melatonin in neonatal diseases. / Gitto, Eloisa; Marseglia, Lucia; Manti, Sara; D'Angelo, Gabriella; Barberi, Ignazio; Salpietro, Carmelo; Reiter, Russel J.

In: Oxidative Medicine and Cellular Longevity, 2013.

Research output: Contribution to journalArticle

Gitto E, Marseglia L, Manti S, D'Angelo G, Barberi I, Salpietro C et al. Protective role of melatonin in neonatal diseases. Oxidative Medicine and Cellular Longevity. 2013. 980374. https://doi.org/10.1155/2013/980374
Gitto, Eloisa ; Marseglia, Lucia ; Manti, Sara ; D'Angelo, Gabriella ; Barberi, Ignazio ; Salpietro, Carmelo ; Reiter, Russel J. / Protective role of melatonin in neonatal diseases. In: Oxidative Medicine and Cellular Longevity. 2013.
@article{bbe766930a3741f5873ec3dfd0f315bb,
title = "Protective role of melatonin in neonatal diseases",
abstract = "Oxidative stress contributes to the severity of several newborn conditions to the extent that Saugstad coined the phrase {"}oxygen radical diseases of neonatology.{"} In order to counteract free radicals damage many strategies to augment antioxidant status in ill-term and preterm infants have been proposed and several medications have been experimented with mixed results. Several studies have tested the efficacy of melatonin to counteract oxidative damage in diseases of newborns such as chronic lung disease, perinatal brain injury, necrotizing enterocolitis, and retinopathy of prematurity, giving promising results. The peculiar perinatal susceptibility to oxidative stress indicates that prophylactic use of antioxidants as melatonin could help to prevent or at least reduce oxidative stress related diseases in newborns. However, more studies are needed to confirm these beneficial effects.",
author = "Eloisa Gitto and Lucia Marseglia and Sara Manti and Gabriella D'Angelo and Ignazio Barberi and Carmelo Salpietro and Reiter, {Russel J}",
year = "2013",
doi = "10.1155/2013/980374",
language = "English (US)",
journal = "Oxidative Medicine and Cellular Longevity",
issn = "1942-0900",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Protective role of melatonin in neonatal diseases

AU - Gitto, Eloisa

AU - Marseglia, Lucia

AU - Manti, Sara

AU - D'Angelo, Gabriella

AU - Barberi, Ignazio

AU - Salpietro, Carmelo

AU - Reiter, Russel J

PY - 2013

Y1 - 2013

N2 - Oxidative stress contributes to the severity of several newborn conditions to the extent that Saugstad coined the phrase "oxygen radical diseases of neonatology." In order to counteract free radicals damage many strategies to augment antioxidant status in ill-term and preterm infants have been proposed and several medications have been experimented with mixed results. Several studies have tested the efficacy of melatonin to counteract oxidative damage in diseases of newborns such as chronic lung disease, perinatal brain injury, necrotizing enterocolitis, and retinopathy of prematurity, giving promising results. The peculiar perinatal susceptibility to oxidative stress indicates that prophylactic use of antioxidants as melatonin could help to prevent or at least reduce oxidative stress related diseases in newborns. However, more studies are needed to confirm these beneficial effects.

AB - Oxidative stress contributes to the severity of several newborn conditions to the extent that Saugstad coined the phrase "oxygen radical diseases of neonatology." In order to counteract free radicals damage many strategies to augment antioxidant status in ill-term and preterm infants have been proposed and several medications have been experimented with mixed results. Several studies have tested the efficacy of melatonin to counteract oxidative damage in diseases of newborns such as chronic lung disease, perinatal brain injury, necrotizing enterocolitis, and retinopathy of prematurity, giving promising results. The peculiar perinatal susceptibility to oxidative stress indicates that prophylactic use of antioxidants as melatonin could help to prevent or at least reduce oxidative stress related diseases in newborns. However, more studies are needed to confirm these beneficial effects.

UR - http://www.scopus.com/inward/record.url?scp=84890047492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890047492&partnerID=8YFLogxK

U2 - 10.1155/2013/980374

DO - 10.1155/2013/980374

M3 - Article

JO - Oxidative Medicine and Cellular Longevity

JF - Oxidative Medicine and Cellular Longevity

SN - 1942-0900

M1 - 980374

ER -